We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Fast Diagnosis of Infections Affecting Women

By HospiMedica staff writers
Posted on 07 Jul 2006
A range of new products have been developed to provide fast and efficient diagnosis of women's infections.

Inverness Medical Professional Diagnostics (Princeton, NJ, USA) developed these products, utilizing optical immunoassay (OIA) technology. More...
The BioStar OIA technology permits direct visual detection of the physical change in optical thickness of molecular thin films resulting from the binding reactions between antibodies and antigens. The signal is generated by the change in the reflection of light through the molecular thin films formed on an optical substrate.

White light reflected through the molecular thin film results in a predominant visual background gold color. Changes in the thickness of the optical molecular thin film will alter this gold color. The change occurs when antigens in liquid samples bind with immobilized antibodies. Because this binding reaction increases the thickness of the film, it changes the optical path through it and the gold color changes to blue or purple, indicating a positive result.

The BioStar OIA Streptococcus B test is a simple, rapid diagnostic test that provides results in just 21 minutes and helps monitor mothers during labor and delivery. The test identifies mothers at risk of delivering a group B Streptococcus (GBS) baby directly from cervical or vaginal swabs. This allows time for adequate prevention measures to be commenced, such as antibiotics during delivery, which reduces transmission of GBS from mother to child.

Timing is also the key to tackling chlamydia because one in four patients diagnosed with the disease do not return for follow-up treatment. Rapid diagnosis is vital as treatment delays of as little as three days from the onset of symptoms can result in infertility and/or ectopic pregnancies. A BioStar OIA Chlamydia test meets this need.

The BioStar OIA GC test is a rapid assay for the diagnosis of gonorrhea. BioStar OIA GC is a specific, rapid test for the detection of Neisseria gonorrhoeae (GC) from an endocervical swab for females or from male urine specimens. The BioStar OIA range of tests is designed for use by healthcare professionals in hospitals, clinics, laboratories, and other point-of-care settings.


Related Links:
Inverness Medical Professional Diagnostics

Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Rapid Sepsis Test
SeptiCyte RAPID
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.